COPD and co-morbidities, with special emphasis on cardiovascular conditions
(2008) Workshop on Respiratory Epidemiologic Research 2. p.59-63- Abstract
- The concept of COPD as a systemic disease has been widely accepted in the past several years. In parallel, it has been emphasised that COPD morbidity and mortality is strongly related to co-morbid conditions. This review summarises some recent studies showing that in patients with COPID, the prevalence of cardiac failure is manifested in 10%-46% of the patients, and that up to 40% of patients with cardiac failure show evidence of COPD, about half of them not earlier diagnosed. Recent data also show an increased risk for arteriosclerotic manifestations in COPD patients, and cardiac complications are common causes of death in COPD patients. Other manifestations of the metabolic syndrome, as diabetes, are also over-represented in patients. It... (More)
- The concept of COPD as a systemic disease has been widely accepted in the past several years. In parallel, it has been emphasised that COPD morbidity and mortality is strongly related to co-morbid conditions. This review summarises some recent studies showing that in patients with COPID, the prevalence of cardiac failure is manifested in 10%-46% of the patients, and that up to 40% of patients with cardiac failure show evidence of COPD, about half of them not earlier diagnosed. Recent data also show an increased risk for arteriosclerotic manifestations in COPD patients, and cardiac complications are common causes of death in COPD patients. Other manifestations of the metabolic syndrome, as diabetes, are also over-represented in patients. It is also a well-established fact that a low FEV1 is a risk factor for cardiovascular diseases and events. Mechanistically, a systemic inflammation in COPD could be a link to cardiovascular events. COPD raises inflammatory parameters and local anti-inflammatory treatment seems to have a potential to decrease the systemic inflammation and also to decrease cardiovascular events. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1286785
- author
- Löfdahl, Claes-Göran LU
- organization
- publishing date
- 2008
- type
- Chapter in Book/Report/Conference proceeding
- publication status
- published
- subject
- keywords
- systemic inflammation, mortality, morbidity, chronic airway obstruction, cardiovascular diseases
- host publication
- CLINICAL RESPIRATORY JOURNAL
- volume
- 2
- pages
- 59 - 63
- publisher
- Wiley-Blackwell
- conference name
- Workshop on Respiratory Epidemiologic Research
- conference dates
- 2007-08-18 - 2007-08-21
- external identifiers
-
- wos:000259610500008
- scopus:77953625127
- ISSN
- 1752-6981
- 1752-699X
- DOI
- 10.1111/j.1752-699X.2008.00085.x
- language
- English
- LU publication?
- yes
- id
- 1dd55d4f-66ae-42dc-86e1-259435d2b6fe (old id 1286785)
- date added to LUP
- 2016-04-01 11:57:03
- date last changed
- 2024-01-08 02:36:28
@inproceedings{1dd55d4f-66ae-42dc-86e1-259435d2b6fe,
abstract = {{The concept of COPD as a systemic disease has been widely accepted in the past several years. In parallel, it has been emphasised that COPD morbidity and mortality is strongly related to co-morbid conditions. This review summarises some recent studies showing that in patients with COPID, the prevalence of cardiac failure is manifested in 10%-46% of the patients, and that up to 40% of patients with cardiac failure show evidence of COPD, about half of them not earlier diagnosed. Recent data also show an increased risk for arteriosclerotic manifestations in COPD patients, and cardiac complications are common causes of death in COPD patients. Other manifestations of the metabolic syndrome, as diabetes, are also over-represented in patients. It is also a well-established fact that a low FEV1 is a risk factor for cardiovascular diseases and events. Mechanistically, a systemic inflammation in COPD could be a link to cardiovascular events. COPD raises inflammatory parameters and local anti-inflammatory treatment seems to have a potential to decrease the systemic inflammation and also to decrease cardiovascular events.}},
author = {{Löfdahl, Claes-Göran}},
booktitle = {{CLINICAL RESPIRATORY JOURNAL}},
issn = {{1752-6981}},
keywords = {{systemic inflammation; mortality; morbidity; chronic airway obstruction; cardiovascular diseases}},
language = {{eng}},
pages = {{59--63}},
publisher = {{Wiley-Blackwell}},
title = {{COPD and co-morbidities, with special emphasis on cardiovascular conditions}},
url = {{http://dx.doi.org/10.1111/j.1752-699X.2008.00085.x}},
doi = {{10.1111/j.1752-699X.2008.00085.x}},
volume = {{2}},
year = {{2008}},
}